Related Experiment Video
Updated: Jul 15, 2026

07:59
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.1K
The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the
Kwun M Fong1, Adam Rosenthal2, Dorothy J Giroux2
1Department of Thoracic Medicine, The Prince Charles Hospital, University of Queensland Thoracic Research Centre, Brisbane, Australia.
Summary
This study suggests refining the M1c category for non-small cell lung cancer (NSCLC) staging. It proposes dividing M1c into M1c1 and M1c2 based on the number of extrathoracic organ systems involved, improving prognostic accuracy.
Area of Science:
- Oncology
- Medical Diagnostics
- Cancer Staging
Background:
- Non-small cell lung cancer (NSCLC) staging relies on the TNM classification.
- The M component of TNM classification requires refinement for improved accuracy.
- Current M categories may not fully capture prognostic differences in advanced NSCLC.
Purpose of the Study:
- To analyze metastatic categories in NSCLC for proposed modifications to the TNM classification's M component.
- To enhance the prognostic accuracy of NSCLC staging for the upcoming ninth edition.
- To evaluate the prognostic impact of metastatic lesion burden and organ involvement.
Main Methods:
- Analysis of a large database (124,581 patients, 2011-2019) focusing on advanced NSCLC (stages IVA-IVB).
- Utilized Kaplan-Meier method for overall survival analysis.
- Employed multivariable-adjusted Cox proportional hazards regression to assess prognosis.
Main Results:
- The eighth edition M categories showed good discrimination in the analyzed dataset.
- Increasing number of metastatic lesions correlated with decreasing prognosis, but a specific number was not suitable for staging.
- Involvement of multiple extrathoracic organ systems significantly worsened prognosis compared to single organ involvement.
- M1c patients with single extrathoracic organ metastasis were prognostically distinct from those with multiple extrathoracic organ involvement.
Conclusions:
- The M1a and M1b categories of the eighth edition TNM classification are validated and recommended for continuation.
- A proposal is made to subdivide the M1c category into M1c1 (single extrathoracic organ system) and M1c2 (multiple extrathoracic organ systems).
- This subdivision aims to provide more precise prognostic stratification for advanced NSCLC patients.

